Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis - Archive ouverte HAL Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2018

Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis

(1, 2) , (1, 2) , (3, 4) , (5, 6) , (7, 8) , (9, 10) , (11) , (7, 8)
1
2
3
4
5
6
7
8
9
10
11
Not file

Dates and versions

hal-01935071 , version 1 (26-11-2018)

Identifiers

  • HAL Id : hal-01935071 , version 1

Cite

F. Rollot, Romain Casey, Marc Debouverie, Gilles Edan, S. Wiertlewski, et al.. Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 2018, 24, pp.344-345. ⟨hal-01935071⟩
60 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More